Literature DB >> 24697860

Hypotrichosis-lymphedema-telangiectasia-renal defect associated with a truncating mutation in the SOX18 gene.

S Moalem1, P Brouillard, D Kuypers, E Legius, E Harvey, G Taylor, M Francois, M Vikkula, D Chitayat.   

Abstract

SOX18 mutations in humans are associated with both recessive and dominant hypotrichosis-lymphedema-telangiectasia syndrome (HLTS). We report two families with affected children carrying a SOX18 mutation: a living patient and his stillborn brother from Canada and a Belgian patient. The two living patients were diagnosed with HLTS and DNA analysis for the SOX18 gene showed that both had the identical heterozygous C > A transversion, resulting in a pre-mature truncation of the protein, lacking the transactivation domain. Both living patients developed renal failure with severe hypertension in childhood for which both underwent renal transplantation. To our best knowledge this is the first report of renal failure associated with heterozygous mutations in the SOX18 gene. We conclude that this specific mutation results in a new, autosomal dominant condition and propose the acronym HLT-renal defect syndrome for HLTRS.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HLTRS; HLTS; SOX18 gene; lymphatics; lymphedema; mosaicism; renal failure

Mesh:

Substances:

Year:  2014        PMID: 24697860     DOI: 10.1111/cge.12388

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

Review 1.  SOXopathies: Growing Family of Developmental Disorders Due to SOX Mutations.

Authors:  Marco Angelozzi; Véronique Lefebvre
Journal:  Trends Genet       Date:  2019-07-06       Impact factor: 11.639

2.  Low Efficacy of Genetic Tests for the Diagnosis of Primary Lymphedema Prompts Novel Insights into the Underlying Molecular Pathways.

Authors:  Gabriele Bonetti; Stefano Paolacci; Michele Samaja; Paolo Enrico Maltese; Sandro Michelini; Serena Michelini; Silvia Michelini; Maurizio Ricci; Marina Cestari; Astrit Dautaj; Maria Chiara Medori; Matteo Bertelli
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

Review 3.  Role of Transcriptional and Epigenetic Regulation in Lymphatic Endothelial Cell Development.

Authors:  Hyeonwoo La; Hyunjin Yoo; Young Bin Park; Nguyen Xuan Thang; Chanhyeok Park; Seonho Yoo; Hyeonji Lee; Youngsok Choi; Hyuk Song; Jeong Tae Do; Kwonho Hong
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

4.  Homodimerization regulates an endothelial specific signature of the SOX18 transcription factor.

Authors:  Mehdi Moustaqil; Frank Fontaine; Jeroen Overman; Alex McCann; Timothy L Bailey; Paulina Rudolffi Soto; Akshay Bhumkar; Nichole Giles; Dominic J B Hunter; Yann Gambin; Mathias Francois; Emma Sierecki
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

5.  A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity.

Authors:  Alex J McCann; Jieqiong Lou; Mehdi Moustaqil; Matthew S Graus; Ailisa Blum; Frank Fontaine; Hui Liu; Winnie Luu; Paulina Rudolffi-Soto; Peter Koopman; Emma Sierecki; Yann Gambin; Frédéric A Meunier; Zhe Liu; Elizabeth Hinde; Mathias Francois
Journal:  Nucleic Acids Res       Date:  2021-11-08       Impact factor: 16.971

Review 6.  Cell Fate Determination of Lymphatic Endothelial Cells.

Authors:  Young Jae Lee
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

7.  Advantages and Challenges of Cardiovascular and Lymphatic Studies in Zebrafish Research.

Authors:  Massimo M Santoro; Monica Beltrame; Daniela Panáková; Arndt F Siekmann; Natascia Tiso; Marina Venero Galanternik; Hyun Min Jung; Brant M Weinstein
Journal:  Front Cell Dev Biol       Date:  2019-05-28

Review 8.  Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies.

Authors:  Ethan J Kilmister; Lauren Hansen; Paul F Davis; Sean R R Hall; Swee T Tan
Journal:  Front Surg       Date:  2021-02-09

Review 9.  Personalized Therapy for Generalized Lymphatic Anomaly/Gorham-Stout Disease With a Combination of Sunitinib and Taxol.

Authors:  Jochen Rössler; Ulrich Saueressig; Gian Kayser; Moritz von Winterfeld; Gianoula L Klement
Journal:  J Pediatr Hematol Oncol       Date:  2015-11       Impact factor: 1.289

10.  R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma.

Authors:  Jeroen Overman; Frank Fontaine; Jill Wylie-Sears; Mehdi Moustaqil; Lan Huang; Marie Meurer; Ivy Kim Chiang; Emmanuelle Lesieur; Jatin Patel; Johannes Zuegg; Eddy Pasquier; Emma Sierecki; Yann Gambin; Mohamed Hamdan; Kiarash Khosrotehrani; Gregor Andelfinger; Joyce Bischoff; Mathias Francois
Journal:  Elife       Date:  2019-07-30       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.